Home › Funds › Aldebaran Capital, LLC › ACRS

Aldebaran Capital, LLC position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

Aldebaran Capital, LLC reported holding 936,185 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.9M, representing 3.54% of its reported portfolio and ranking #10 among its reported holdings. Aldebaran Capital, LLC has disclosed ACRS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)936.18K sh
Reported value held$4.92M
Portfolio Weight3.54%
First reportedQ2 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aldebaran Capital, LLC's ACRS position evolved

Aldebaran Capital, LLC first disclosed a stake in ACRS in Q2 2024 at 858,152 shares (US$944K). The position peaked in Q2 2026 at 936,731 shares, worth US$5.0M. Across 10 filings, Aldebaran Capital, LLC increased the stake 1 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 936,185 shares valued at US$4.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 858.15K $943.97K New
Q3 2024 1.04M $1.20M Add
Q4 2024 1.02M $2.52M Reduce
Q1 2025 1.01M $1.54M Reduce
Q2 2025 993.70K $1.41M Reduce
Q3 2025 987.70K $1.88M Reduce
Q4 2025 954.26K $2.87M Reduce
Q1 2026 947.16K $3.55M Reduce
Q2 2026 936.73K $4.96M Reduce
Q3 2026 936.18K $4.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has Aldebaran Capital, LLC held ACRS?

Aldebaran Capital, LLC has disclosed ACRS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Aldebaran Capital, LLC's current position in ACRS?

As of Q3 2026, Aldebaran Capital, LLC holds 936.18K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $4.92M, representing 3.54% of its reported portfolio and ranking #10.

Has Aldebaran Capital, LLC been buying or selling ACRS?

In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC held unchanged its position in ACRS. The position peaked in Q2 2026 at 936.73K shares.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.